Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Current Taxes (2019 - 2022)

Nurix Therapeutics (NRIX) has disclosed Current Taxes for 2 consecutive years, with $75000.0 as the latest value for Q4 2021.

  • On a quarterly basis, Current Taxes rose 1.35% to $75000.0 in Q4 2021 year-over-year; TTM through Nov 2021 was $75000.0, a 1.35% increase, with the full-year FY2021 number at $75000.0, up 1.35% from a year prior.
  • Current Taxes was $75000.0 for Q4 2021 at Nurix Therapeutics, down from $325000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $325000.0 in Q1 2021 to a low of $74000.0 in Q4 2020.